175 related articles for article (PubMed ID: 27031095)
1. Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity.
Chandra J; Miao Y; Romoff N; Frazer IH
PLoS One; 2016; 11(3):e0152886. PubMed ID: 27031095
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction.
Kuo P; Teoh SM; Tuong ZK; Leggatt GR; Mattarollo SR; Frazer IH
Front Immunol; 2018; 9():2896. PubMed ID: 30619266
[TBL] [Abstract][Full Text] [Related]
3. HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation and Regulatory T-Cell Development.
Bashaw AA; Teoh SM; Tuong ZK; Leggatt GR; Frazer IH; Chandra J
J Invest Dermatol; 2019 Dec; 139(12):2467-2476.e3. PubMed ID: 31207230
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
5. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
6. Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors.
Matsumoto K; Leggatt GR; Zhong J; Liu X; de Kluyver RL; Peters T; Fernando GJ; Liem A; Lambert PF; Frazer IH
J Natl Cancer Inst; 2004 Nov; 96(21):1611-9. PubMed ID: 15523090
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice.
Jemon K; Leong CM; Ly K; Young SL; McLellan AD; Hibma MH
Sci Rep; 2016 Oct; 6():34789. PubMed ID: 27708419
[TBL] [Abstract][Full Text] [Related]
8. Detection of HPV E7 Transcription at Single-Cell Resolution in Epidermis.
Lukowski SW; Tuong ZK; Noske K; Senabouth A; Nguyen QH; Andersen SB; Soyer HP; Frazer IH; Powell JE
J Invest Dermatol; 2018 Dec; 138(12):2558-2567. PubMed ID: 29964033
[TBL] [Abstract][Full Text] [Related]
9. Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.
Tuong ZK; Noske K; Kuo P; Bashaw AA; Teoh SM; Frazer IH
Papillomavirus Res; 2018 Jun; 5():6-20. PubMed ID: 29807614
[TBL] [Abstract][Full Text] [Related]
10. Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors.
Wang Z; Wei C; Zhang Y; Wang W; Zhou Z; Xiao G
Oncol Rep; 2018 Jan; 39(1):425-432. PubMed ID: 29115562
[TBL] [Abstract][Full Text] [Related]
11. Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.
Heller C; Weisser T; Mueller-Schickert A; Rufer E; Hoh A; Leonhardt RM; Knittler MR
J Biol Chem; 2011 Apr; 286(13):10983-97. PubMed ID: 21321113
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
13. IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia.
Gosmann C; Mattarollo SR; Bridge JA; Frazer IH; Blumenthal A
J Immunol; 2014 Sep; 193(5):2248-57. PubMed ID: 25063870
[TBL] [Abstract][Full Text] [Related]
14. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism.
Tran LS; Bergot AS; Mattarollo SR; Mittal D; Frazer IH
J Invest Dermatol; 2014 Sep; 134(9):2438-2446. PubMed ID: 24732401
[TBL] [Abstract][Full Text] [Related]
16. RNA interference of human papillomavirus type 16 E7 increases HLA class I antigen expression in HaCaT-E7 cells.
Deng XM; Li W; Zhang X; Wang CX; Dong ZG; Zhang X; Zheng GX; Zhang XH; Zheng N; Wang LL; Du LT; Wang S
Int J Gynecol Cancer; 2011 Jan; 21(1):28-34. PubMed ID: 21330828
[TBL] [Abstract][Full Text] [Related]
17. A Genetically Modified attenuated
Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
[TBL] [Abstract][Full Text] [Related]
18. HPV16 E7-impaired keratinocyte differentiation leads to tumorigenesis via cell cycle/pRb/involucrin/spectrin/adducin cascade.
Ci X; Zhao Y; Tang W; Tu Q; Jiang P; Xue X; Saunders NA; Zhang L; Zhu X; Zhao KN
Appl Microbiol Biotechnol; 2020 May; 104(10):4417-4433. PubMed ID: 32215704
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.
Richards KH; Doble R; Wasson CW; Haider M; Blair GE; Wittmann M; Macdonald A
J Virol; 2014 Apr; 88(8):4173-9. PubMed ID: 24478434
[TBL] [Abstract][Full Text] [Related]
20. PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
Hatterschide J; Bohidar AE; Grace M; Nulton TJ; Kim HW; Windle B; Morgan IM; Munger K; White EA
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7033-7042. PubMed ID: 30894485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
